Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02077166
What this trial is testing

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Pharmacyclics LLC. 138
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Not applicableStudy completedNCT00476229
What this trial is testing

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769
What this trial is testing

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 121
Not applicableLooking for participantsNCT02537769
What this trial is testing

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

Who this might be right for
Tricuspid RegurgitationHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Washington 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729
What this trial is testing

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06687772
What this trial is testing

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT06553872
What this trial is testing

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

Who this might be right for
Mantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT07519772
What this trial is testing

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC 280
Early research (Phase 1)Active Not RecruitingNCT03434769
What this trial is testing

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Benjamin Tomlinson 31
Early research (Phase 1)UnknownNCT05781386
What this trial is testing

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Who this might be right for
Advanced Solid TumorCutaneous T Cell Lymphoma
Jiangsu Simcere Biologics Co., Ltd 255
Not applicableStudy completedNCT01381705
What this trial is testing

Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 259
Testing effectiveness (Phase 2)UnknownNCT02060656
What this trial is testing

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Royal Marsden NHS Foundation Trust 92
Not applicableLooking for participantsNCT06664229
What this trial is testing

Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

Who this might be right for
Dementia, MildAccidental FallsMild Cognitive Impairment
Sunmi Song 205
Testing effectiveness (Phase 2)Ended earlyNCT00372905
What this trial is testing

Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Lymphoma
Northwestern University 18
Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early research (Phase 1)Study completedNCT01969695
What this trial is testing

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 11
Large-scale testing (Phase 3)Looking for participantsNCT05820841
What this trial is testing

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B Cell Lymphoma
Universität des Saarlandes 330
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Next Page